BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
8 hedge funds and large institutions have $697K invested in Biostar Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
8
Holders Change
+2
Holders Change %
+33.33%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $468K | 105,956 | +1,100 | +1% |
|
|
CS
2
Credit Suisse
Zurich,
Switzerland
| $129K | 29,116 | +29,116 | New |
|
3
Jane Street
New York
| $69K | 15,556 | +15,556 | New |
|
4
UBS Group
Zurich,
Switzerland
| $21K | 4,793 | +3,839 | +402% |
|
|
AIM
5
Acrospire Investment Management
Chicago,
Illinois
| $9K | 2,000 | +2,000 | New |
|
6
Bank of America
Charlotte,
North Carolina
| $1K | 143 | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | – | -749 | Closed |
|
8
Morgan Stanley
New York
| $0 | 24 | -4 | -14% |
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 2 | +1 | +100% |
|